Core Viewpoint - The article discusses the upcoming China Industrial Biotechnology Innovation Forum and Bio-Manufacturing Industry Conference, emphasizing its role in promoting high-quality development in synthetic biology and bio-manufacturing through collaboration among various sectors [3][4]. Conference Overview - The conference has been held annually since 2007, becoming a significant platform for communication and cooperation in the field of industrial biotechnology and bio-manufacturing in China [3]. - The theme for the 2025 conference is "Synthetic Biology Drives Bio-Manufacturing," scheduled for October 24-26, 2025, at the Tianjin Binhai Crowne Plaza Hotel [4]. Organizational Structure - The event is organized by several prominent institutions, including the Chinese Society of Biotechnology and the Tianjin Institute of Industrial Biotechnology [4]. Conference Agenda - The agenda includes a registration day, satellite meetings, an opening ceremony, keynote speeches, and multiple sub-forums focusing on various topics such as AI in bio-manufacturing and green biosynthesis of chemicals [5][9]. Keynote Speakers and Topics - Notable speakers include academicians from leading universities discussing topics like microfluidic chemistry and synthetic biology applications [7][10]. Sub-Forum Highlights - Sub-forums will cover diverse topics, including AI empowerment in bio-manufacturing, industrial strain innovation, and green biosynthesis of chemicals, featuring experts from various institutions [8][11][13]. Registration Information - Registration fees are set at 2500 RMB for regular attendees and 1500 RMB for students, with specific details on payment and included services [24][25]. Accommodation Guidelines - Several hotels near the conference venue offer discounted rates for attendees, with prices ranging from 299 RMB to 800 RMB per night, including breakfast [28][29][30]. Contact Information - Contact details for registration, business cooperation, media collaboration, and general inquiries are provided for attendees seeking further information [31].

Core Viewpoint - The 13th China Industrial Biotechnology Innovation Forum and Biomanufacturing Conference aims to promote high-quality development in synthetic biology and biomanufacturing through academic exchanges and collaboration among various sectors [11][12]. Conference Overview - The conference will take place from October 24 to October 26, 2025, at the Crowne Plaza Tianjin Binhai Hotel [12]. - The theme of the conference is "Synthetic Biology Drives Biomanufacturing" [12]. Organizational Structure - The event is organized by the Chinese Society of Biotechnology, the Tianjin Institute of Industrial Biotechnology, and the National Synthetic Biology Innovation Center [12]. Conference Agenda - The agenda includes registration, academic discussions, and various sub-forums focusing on topics such as AI in biomanufacturing, industrial strain innovation, and green biosynthesis of chemicals [13][14][15]. Keynote Speakers and Topics - Notable speakers include academicians from East China Normal University and Tianjin University, discussing topics like microfluidic chemistry and synthetic biology applications [15][17]. Sub-Forums - Sub-forums will cover diverse topics including AI empowerment in biomanufacturing, green biosynthesis, industrial enzyme design, and future food biomanufacturing [18][19][20][21][22][26][27]. Registration Information - Registration fees are set at 2500 RMB for regular attendees and 1500 RMB for students, with specific payment timelines [33]. - Participants can register via a QR code provided in the conference materials [34]. Accommodation Guidelines - Several hotels near the conference venue offer discounted rates for attendees, with prices ranging from 299 RMB to 800 RMB per night [37][39].

Core Insights - Zhejiang Ruiwei New Materials Technology Co., Ltd. has completed a new round of financing amounting to several tens of millions, with the investment coming from Beauty Pioneer Fund, co-founded by L'Oréal and Tiantu Investment in 2025 [2] - The company, established in 2022, focuses on the application of biodegradable materials in the consumer sector, providing integrated solutions from laboratory research, material processing to product manufacturing [2] - Ruiwei New Materials has built two R&D laboratories in collaboration with leading industry players, specializing in packaging and textile applications, and is one of the few companies in the biodegradable materials industry to achieve large-scale commercial use of high-value biodegradable materials [2] Industry Applications - In the packaging sector, Ruiwei New Materials has served over 40 leading domestic and international consumer brands, including Chanel, UPS, Air Asia, and Ziyuan Food [2] - In the fiber sector, the company's self-developed biodegradable fabric has passed FDA medical device registration in the United States and has received high-performance material certifications from international authorities such as Intertek in the UK and Dermatest in Germany [2] Investment and Strategy - Previously, Ruiwei New Materials has received investments from industry leaders and related parties, including Jinhe Industrial, a leader in sugar substitutes, and Shangcheng Capital, a consumer industry VC fund [3] - In the beauty and personal care sector, the company has attracted investment from Haofeng Capital, which is jointly initiated by Huaxi Biotechnology and Beijing Yadi Digital Media [3] - The company aims to adhere to the strategy of "embracing leaders and serving globally," while promoting the national strategy of "green mountains and clear waters are better than mountains of gold and silver," and continues to advance innovation and internationalization of China's green polymer materials [3]

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper outlines the development status and trends of biomanufacturing, analyzing the global landscape and key platform facilities [5]. - It compares the biomanufacturing sectors of China and the United States, identifying competitive advantages and areas for improvement [5]. - Future development trends in biomanufacturing are discussed, indicating a shift towards more integrated and sustainable practices [5]. Group 2: Policy Landscape - The report reviews major policies affecting biomanufacturing both domestically and internationally, providing insights into regulatory frameworks that shape the industry [5]. - It highlights the importance of supportive policies in fostering innovation and growth within the biomanufacturing sector [5]. Group 3: Industry Map and Applications - A comprehensive map of the Chinese biomanufacturing industry is presented, detailing key players and their roles [5]. - The report identifies critical application areas for biomanufacturing, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5]. Group 4: Key Enterprises - The white paper lists the top 10 chain enterprises in China's biomanufacturing industry, showcasing leaders in the field [6]. - It also details the strategic directions of 15 publicly listed companies involved in synthetic biology, summarizing their development strategies [6]. Group 5: Investment and Challenges - An analysis of the investment landscape in synthetic biology from 2024 to mid-2025 is included, providing insights into funding trends and opportunities [6]. - The report discusses challenges faced by the biomanufacturing industry in China, along with targeted policy recommendations to address these issues [6].

投资者提问及金发科技回复的主要内容如下： 1、公司宁波金发和辽宁金发建设的PP和ABS改性一体化装置能多大程度上改善盈利? 答: 公司子公司宁波金发年产15万吨PP改性一体化项目正在加速推进，预计2025年底将逐步建成投产； 同时，辽宁金发年产20万吨改性ABS一体化项目已实现部分产能投产，剩余产能建设也在稳步推进。 公司通过"合成改性一体化"布局，整合树脂合成与材料改性环节，有效缩短了生产流程，在提升产品稳 定性的同时降低生产成本，进一步增强公司绿色石化板块及改性塑料板块的市场竞争力。 2025年上半年，公司绿色石化板块持续加强与改性塑料板块产业链协同，通过技改升级和工艺优化实 现降本增效，并积极开发高端专用料产品以及加快合成改性一体化项目进程，公司绿色石化业务毛利同 比减亏36.67%，盈利能力有所改善。 展望未来，随着改性一体化项目的全面投产，公司将进一步发挥产业链协同优势，通过优化产品结构、 提升装置产能利用率等举措， 持续推动绿色石化板块经营业绩改善。 2、改性塑料未来市场的需求是怎么样的，公司改性塑料业务的 增长规划? 答: 改性塑料凭借其优异的加工性能和高性价比，已在汽车、家电、电子电工、新能源 ...

创新论坛旨在汇聚产学研金各界嘉宾,围绕生物制造 前沿创新、产业发展展开深入学术交流研讨,赋能新质 生产力,进一步促进创新链、产业链、资本链、人才链 的深度融合,为推动我国合成生物学和生物制造产业高 质量发展启迪新思想、注入新活力、蓄积新动能。 二、会议基本信息 大会主题: 合成生物,驱动生物制造 、会议简介 中国工业生物技术创新论坛暨生物制造产业大会自 2007 年举办第一届迄今已成功举办十二届， 为领域内 研发机构和企业搭建了交流、展示、对接、合作的重要 平台,已成为我国工业生物技术与生物制造领域历史悠 久、层次高、规模大、影响广的品牌盛会。 大会时间: 2025年10月24日-10月26日 (10月24日报到) 大会地点: 天津滨海圣光皇冠假日酒店（天津市空港经济区中心大 道55号） 三、组织架构 主办单位: 中国生物工程学会 中国科学院天津工业生物技术研究所 国家合成生物技术创新中心 承办单位: 低碳合成工程生物学全国重点实验室 天津国家合成生物技术创新中心有限公司 享融智云(上海)信息科技有限公司(SYNBIO深波) 四、会议日程(暂定) | | | 内容 | | | 大会报到注册(9:00-18:0 ...

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper outlines the development status and trends of biomanufacturing, analyzing the global landscape and key platform facilities [5]. - It compares the biomanufacturing sectors of China and the United States, identifying competitive advantages and areas for improvement [5]. - Future development trends in biomanufacturing are discussed, indicating a shift towards more integrated and sustainable practices [5]. Group 2: Policy Landscape - The report reviews major policies affecting biomanufacturing both domestically and internationally, providing insights into regulatory frameworks that shape the industry [5]. - It highlights the importance of supportive policies in fostering innovation and growth within the biomanufacturing sector [5]. Group 3: Industry Map and Applications - A comprehensive map of the Chinese biomanufacturing industry is presented, detailing key players and their roles [5]. - The report identifies critical application areas for biomanufacturing, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5]. Group 4: Key Enterprises - The white paper lists the top 10 leading enterprises in China's biomanufacturing industry, showcasing their contributions and market positions [6]. - It also details the strategic directions of 15 publicly listed companies in the field of synthetic biology, summarizing their development strategies [6]. Group 5: Investment and Challenges - The report examines the investment landscape in synthetic biology from 2024 to mid-2025, providing data on funding trends and investor interest [6]. - It discusses the challenges faced by the biomanufacturing industry in China, including technological barriers and market competition, and offers targeted policy recommendations to address these issues [6].

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field, which is seen as a new growth point that can drive industrial structure optimization and economic transformation. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper provides an overview of the global biomanufacturing industry, including its development status and trends [5]. - It compares the biomanufacturing sectors of China and the United States, highlighting competitive dynamics [5]. - Future development trends in biomanufacturing are discussed, indicating potential growth areas [5]. Group 2: Policy Landscape - The report outlines major policies affecting biomanufacturing both domestically and internationally for the years 2024-2025 [5]. - It details foreign biomanufacturing industry policies and their implications for the sector [5]. - Domestic policies related to biomanufacturing are also analyzed, providing insights into regulatory frameworks [5]. Group 3: Industry Map and Applications - The white paper presents a comprehensive map of the Chinese biomanufacturing industry, identifying key players and their roles [5]. - It analyzes the biomanufacturing industry chain and key application areas, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5][6]. - Specific applications of biomanufacturing in various sectors are highlighted, showcasing its versatility and potential impact [5]. Group 4: Key Enterprises and Investment Landscape - The report identifies ten leading enterprises in the Chinese biomanufacturing industry, providing insights into their operations and market positions [6]. - It summarizes the strategic directions of 15 listed companies in synthetic biology, indicating their focus areas and growth strategies [6]. - The investment landscape for synthetic biology in China is examined, detailing funding trends and opportunities from 2024 to mid-2025 [6]. Group 5: Challenges and Recommendations - The white paper discusses the challenges faced by the biomanufacturing industry in China, including technological, regulatory, and market-related issues [6]. - It offers targeted policy recommendations to address these challenges, aiming to support the sustainable development of the biomanufacturing sector [6].

10月6日， 中国科学院深圳先进技术研究院定量合成生物学全国重点实验室、合成生物学研究所高翔团队 联合 电子科技大学夏川团队 ， 首次提出并验 证了一种基于"电催化+生物催化"耦合策略的"人工海洋碳循环系统" ，相关成果发表在国际学术期刊《自然·催化》。 该系统可捕集天然海水中的CO₂， 并转化为可直接进入生物制造的中间体，再进一步升级为多类高价值化学品与材料 。该研究以可降解塑料单体为示范案例，有望为燃料、医药与食品配 料等更广谱产品提供生物制造平台。 研究的首个关键环节由电子科技大学夏川团队负责。他们利用电催化技术实现了从海水中进行高效的碳捕集。面对电极钝化和盐类沉积等难题，研究团队 设计了一种新型电解装置。实验结果显示， 该装置能在天然海水里连续稳定运行超500小时，二氧化碳捕碳效率有70%以上，还可同步副产氢气 。同 时，研究团队成功研制出高活性、高甲酸选择性的铋基催化剂，借助电催化将捕获的二氧化碳高效转化为甲酸，并持续获得高浓度甲酸溶液。 声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文由作者重新编写，仅作新材料相关领域介绍，本文不构成任何投资建议！转载请注明来源！ 海洋作为 ...

、会议简介 二、会议基本信息 大会主题: 合成生物,驱动生物制造 大会时间: 2025年10月24日-10月26日 (10月24日报到) 大会地点: 天津滨海圣光皇冠假日酒店（天津市空港经济区中心大 道55号） 三、组织架构 中国工业生物技术创新论坛暨生物制造产业大会自 2007 年举办第一届迄今已成功举办十二届， 为领域内 研发机构和企业搭建了交流、展示、对接、合作的重要 平台,已成为我国工业生物技术与生物制造领域历史悠 久、层次高、规模大、影响广的品牌盛会。 创新论坛旨在汇聚产学研金各界嘉宾,围绕生物制造 前沿创新、产业发展展开深入学术交流研讨,赋能新质 生产力,进一步促进创新链、产业链、资本链、人才链 的深度融合,为推动我国合成生物学和生物制造产业高 质量发展启迪新思想、注入新活力、蓄积新动能。 主办单位: 中国生物工程学会 中国科学院天津工业生物技术研究所 国家合成生物技术创新中心 承办单位: 低碳合成工程生物学全国重点实验室 天津国家合成生物技术创新中心有限公司 享融智云(上海)信息科技有限公司(SYNBIO深波) 四、会议日程(暂定) | | | 内容 拟定时间:10月25日(周六)下午 召集人: ...